Clinical Trials Directory

Trials / Completed

CompletedNCT03103984

Immunosuppression and Diet: the Role of Inflammation in the Adipose Tissue Remodeling

Immunosuppression and Diet: the Role of Inflammation in the Adipose Tissue Remodeling After Liver Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Federal University of Minas Gerais · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The main goal of this project is to evaluate the effect of immunosuppression in the weight loss and in the metabolic status of patients after liver transplantation. It is also the purpose of this project to investigate why patients become overweight and obese after liver transplantation.

Detailed description

Overweight and obese post-liver transplantation patients will receive a diet to promote weight loss during 6 months. The control group (overweight and obese subjects) will be submitted to the same protocol: The participants will be interviewed at baseline and after 30, 60, 90 and 180 days from baseline. The following measures will be assessed: body composition (fat body% and free fat body%), anthropometric measures (height, weight, body mass index, waist circumference and abdominal circumference), blood pressure, basal metabolic rate, behavioral symptoms and peripheral biomarkers in the serum. Behavioral symptoms will be assessed using the following self-reported questionnaires: Beck Depression Inventory (depression symptoms), Beck Anxiety Inventory (anxiety symptoms), Medical Outcomes Study 36 - Item Short - Form Health Survey (quality of life) and Perceived Stress Scale (stress). Enrolled participants will receive a restrictive diet calculated based on individual requirements aiming the loss of around 5%-10% of weight/ 6 months of intervention.

Conditions

Interventions

TypeNameDescription
OTHERWeight loss dietWeight loss diet composed of 30% lipids, 30% proteins and 40% carbohydrates.

Timeline

Start date
2014-07-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2017-04-07
Last updated
2018-06-26

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03103984. Inclusion in this directory is not an endorsement.